Lupin Pharmaceuticals Inc. has recalled 13,896 bottles of Moxifloxacin Ophthalmic Solution USP, 0.5% (generic Vigamox), a prescription antibiotic eye drop used to treat bacterial infections. The recall was initiated because long-term stability testing showed the medicine exceeded allowed levels for impurities and degradation products after three months of storage. Consumers who have this medication should contact their doctor or pharmacist for guidance on continuing treatment with a different batch.
The presence of impurities or degradation products that exceed safety specifications can reduce the effectiveness of the antibiotic and potentially cause irritation or other adverse reactions when applied to the eye.
Drug Recall Refund/Guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.